SEARCH:   Advanced

Prepublished online as a Blood First Edition Paper on April 17, 2002; DOI 10.1182/blood-2001-12-0196. This Article Abstract Full Text (PDF) All Versions of this Article: 2001-12-0196v1 100/1/11    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kim, C. H. Articles by Butcher, E. C. Search for Related Content PubMed PubMed Citation Articles by Kim, C. H. Articles by Butcher, E. C. Related Collections Immunobiology Chemokines, Cytokines, and Interleukins Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 July 2002, Vol. 100, No. 1, pp. 11-16 CHEMOKINES Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V24+V11+ NKT cell subsets with distinct cytokine-producing capacity Chang H. Kim, Brent Johnston, and Eugene C. Butcher From the Laboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, CA; and Center for Molecular Biology and Medicine, Veterans Affairs Palo Alto Health Care System, CA.     Abstract Top Abstract Introduction Materials and methods Results Discussion References Natural killer T (NKT) cells are important regulators of the immune system, but their trafficking machinery, including expression of chemokine receptors, has been poorly defined. Unlike other conventional T-cell populations, we show that most NKT cells express receptors for extralymphoid tissue or inflammation-related chemokines (CCR2, CCR5, and CXCR3), while few NKT cells express lymphoid tissue-homing chemokine receptors (CCR7 and CXCR5). A population with homing potential for lymph nodes (L selectin+ CCR7+) exists only within a small subset of CD4 NKT cells. We show differential expression of chemokine receptors among NKT cell subsets: CCR4 is mainly expressed by a high cytokine (interleukin-4/interleukin-2)-producing (CD4) NKT subset, while CCR1, CCR6, and CXCR6 are preferentially expressed by the low cytokine-producing CD8 and CD4CD8 subsets. In line with this, TARC/CCL17 (a CCR4 ligand) induces preferential chemotaxis of the CD4 NKT subset, while chemotactic activities of LARC/CCL20 (a CCR6 ligand) and MIP-1/CCL3 (a CCR1 ligand) are focused on the CD8 and CD4CD8 NKT cells. We conclude that, unlike conventional naive, memory, or effector T cells, the entire NKT cell population expresses nonlymphoid tissue homing chemokine receptors, yet NKT cell subsets differ considerably from each other by displaying distinct and reciprocal expression patterns of some chemokine receptors. Our results identify chemokine receptors that are potentially important for trafficking of human blood NKT cell subsets and reveal their function (cytokine production capacity)-dependent differential trafficking potentials. (Blood. 2002;100:11-16) © 2002 by The American Society of Hematology.     Introduction Top Abstract Introduction Materials and methods Results Discussion References Natural killer T (NKT) cells constitute a unique class of T-lymphocyte lineage that shares some characteristics with NK cells.1,2 These cells have an extremely restricted T-cell receptor (TCR) repertoire, consisting of an invariant V24-JQ chain preferentially paired with a V11 chain in human beings.3,4 Although their natural TCR ligands remain to be identified, NKT cells can be generated and activated by glycolipid antigens such as -galactosylceramide and glycosyl-phosphatidylinositol in the context of CD1d, a 2-microglobulin-associated major histocompatibility complex class I-like molecule.5-7 Human NKT cells express NK-associated NKR-P1 (CD161, the human version of mouse NK1.1) and CD45RO and are heterogeneous in expression of CD4 or CD8.8-11 NKT cells, especially the CD4+ subset, are enriched in type 2 (interleukin-4+ [IL-4+]) and type 0 (IL-4+ interferon-+ [IFN-+]) cells.11-13 NKT cells with distinct cytokine production profiles can be generated by different types of dendritic cells or stimuli.14 Efficicient production of cytokines, particularly IL-4, is important for the regulation of the immune system by inhibition of Th1 and induction of Th2 response. NKT cells have also been implicated in tumor rejection, control of microbial infection, suppression of autoimmune diseases, and graft-versus-host disease after bone marrow transplantation.1,2,15 NKT cells are widely distributed in the body, including bone marrow, liver, thymus, lymph nodes, spleen, and lung.2 Whereas thymus and liver contain primarily CD1d-dependent NKT cells, spleen and bone marrow are enriched in CD1d-independent NKT cells, suggesting differential localization of CD1d-dependent NKT cells from other related T-cell types in mice.16 NKT cells found in different organs or tissues are heterogeneous in production of cytokines.13,16 Chemokines, differentially expressed in tissue and inflammatory microenvironments, guide homing and localization of leukocytes in the body by inducing adhesion and chemotaxis through various cell surface chemokine receptors.17-20 Thus, we postulated that chemokine receptor expression patterns of NKT cell subsets may be distinct from other T-cell subsets to allow their differential tissue localization. We examined chemokine response and receptor expression by different human V24+V11+ NKT cell subsets in circulation. We show that most NKT cells express tissue-homing chemokine receptors and that NKT cell subsets with different cytokine production potentials display distinctive chemokine receptor expression patterns and chemokine responses, differing from each other and from the conventional T cells. We conclude that NKT cells are specialized both in cytokine production and expression of chemokine receptors.     Materials and methods Top Abstract Introduction Materials and methods Results Discussion References Reagents Antibodies to IFN- (4S.B3), IL-2 (MQ1-17H12), IL-5 (JES1-39D10), CD161 (DX12), CD4 (RPA-T4), CD45RA (HI100), and tumor necrosis factor- (TNF-) (Mab11) were purchased from Pharmingen (San Diego, CA). Antibodies to CD8 (3B5) and CD56 (MEM-188) were from Caltag (Burlingame, CA). Antibodies to CLA (HECA 452) and CD62L (DREG-200) were from our laboratory. Anti-IL4 (3010.211) was from Becton Dickinson (Mountain View, CA). Antibodies to CCR1 (53504.111) CCR2 (48607.121), CCR5 (45549.111), CCR6 (53103.111), CXCR3 (49801.111), CXCR6 (56 811.111), and CXCR5 (51505.111) were from R&D Systems (Minneapolis, MN). Antibodies to 47 (Act-1), CCR3 (7B11), CCR4 (1G1), CCR7 (7H12-12-2), and CCR9 (GPR96-1) were from Millennium Pharmaceuticals (Cambridge, MA). Human chemokines, thymus and activation-regulated chemokine (TARC), interferon  inducible protein-10 (IP-10), B lymphocyte chemoattractant (BLC), I-309, EBI-1-ligand chemokine (ELC), and macrophage-inflammatory protein-1 (MIP-1) were from R&D Systems. Human liver and activation-regulated chemokine (LARC) was from PeproTech (Rocky Hill, NJ). All antibodies to chemokine receptors have been tested on positive control cells. The anti-CCR3 used in this study binds to eosinophils.21 The anti-CCR9 used in this study binds to naive and memory T cells.22 The batches of each antibody used in the current study were shown to react with eosinophils or gut homing lymphocyte subsets as well. NKT cell preparation For NKT cell sources, unseparated peripheral blood mononuclear cells (for chemokine receptor analysis) (Stanford University Blood Center) or isolated V11+ T cells were used (for chemotaxis and cytokine analysis). Peripheral blood mononuclear cells were prepared by density gradient centrifuge on Histopaque-1077 (Sigma, St Louis, MO). TCR V11+ T cells were isolated with anti-V11-biotin and streptavidin beads and sorted by a magnetic method (V11+ cells > 99%, Miltenyi Biotec, Auburn, CA). Chemokine receptor expression Peripheral blood mononuclear cells were sequentially stained with anti-CKR, antimouse immunoglogulin G (IgG)-biotin and streptavidin-allophycocyanin plus anti-V24-fluorescein isothiocyanate (FITC), anti-V-11-phycoerythrin, and other antibodies to various surface antigens (eg, CD4, CD8, CD56, CD161). One million cells were acquired for each fluorescence-activated cell sorter analysis. Isotype-matched mouse antibodies (IgG1, IgG2a, and IgG2b) were used to control the chemokine receptor expression. Antibodies to CCR1, CCR2, CCR5, CCR6, CCR7, CCR9, CXCR4, CXCR5, and CXCR6 are IgG2b. Antibodies to CCR4, CCR5, and CXCR3 are IgG1. Anti-CCR3 is IgG2a. All isotype (IgG1, IgG2a, and IgG2b) control antibodies did not stain NKT cells (not shown). Negative controls shown in Figures 1 and 2 were with IgG2b. View larger version (51K): [in this window] [in a new window]   Figure 1. Expression of chemokine receptors by human NKT cells in circulation. (A) Phenotype and frequency (n = 33) of human NKT cells examined in this study. (B) Chemokine receptor expression by V24+ V11+ NKT cells, CD4 (naive CD45RA+ and memory CD45RA), and CD8 (naive CD45RA+CD27+, memory CD45RACD27+, and effector CD45RA+CD27) T-cell subsets. Different symbols represent data from different donors, and horizontal bars represent averages (NKT cells, the upper left panel). Results from 6 donors (NKT cells) or averages ± SD from 4 donors (CD4 and CD8 T-cell subsets) are shown. (C) Chemokine receptor expression by V24+ V11+ NKT cells shown as dot plots. Percentages positive are shown in parentheses. View larger version (50K): [in this window] [in a new window]   Figure 2. Distinct expression pattern of chemokine receptors among NKT cell subsets. (A) Chemokine receptor expression by CD4, CD8, and DN NKT subsets (n = 4). (B) Dot plots of chemokine receptor expression by NKT cell subsets with percentages positive. (C) Relative frequencies of CD4, CD8, and DN NKT cell subsets in the V24+ V11+ NKT cell population (n = 11). (D) Differential cytokine production capacities of NKT cell subsets (n = 5). Isolated V11+ NKT cells were stained with antibodies to V24, CD4, and CD8 and activated with phorbol myristate acetate and ionomycin in the presence of monensin to block internalization of surface antigens followed by intracellular cytokine analyses. Bars indicate averages of results from 4 (A), 11 (C), or 5 (D) donors. *Significant differences from the CD4 NKT subset (P < .05 [A,D]). **Significant difference from CD4 or CD8 subset (P < .02 [C]). Chemotaxis Chemotaxis assays were performed as previously described.23 Isolated TCR V11+ T cells were used as input cells for chemotaxis. A total of 2× 105 to 5 × 105 cells were used per Transwell (Corning, Cambridge, MA) and allowed to chemotax for 3 hours. Chemokines TARC, LARC, MIP-1, ELC, BLC, IP-10, MCP-1, MIP-1, and I-309 were used at indicated concentrations. After chemotaxis, migrated cells in bottom wells were collected and stained with anti-V24-FITC, anti-CD4, and anti-CD8. Numbers of migrated cells and input cells were counted using FACSCalibur (Becton Dickinson), and the percent migrated cells of each cell subset was calculated. Intracellular cytokine production analyses Intracellular cytokine analyses have been performed as previously described.24 Briefly, isolated TCR V11+ T cells were stained with anti-V24-FITC, anti-CD4-allophycocyanin, and anti-CD8-TriColor and activated for 4 hours with phorbol myristate acetate (50 ng/mL) and ionomycin (1 µM) in the presence of monensin (Sigma). Activated T cells were fixed and permeabilized with Cytofix/perm solution (Pharmingen), followed by staining with phycoerythrin-conjugated monoclonal antibodies to cytokines (IL-4, IL-15, IL-10, IL-13, IFN-, and TNF-). Stained cells were analyzed with FACSCalibur and CellQuest program (Becton Dickinson). Only viable cells based upon their forward and side scatter were gated for cytokine analyses. Statistics Comparisons were performed by analysis of variance, and significant differences between groups were tested using a paired Student t test. Statistical significance was set at P < .05.     Results Top Abstract Introduction Materials and methods Results Discussion References Chemokine receptor expression by V24+V11+ NKT cells V24+V11+ NKT cells represent a very small population in blood (on average 0.089% of lymphocytes, n = 33) (Figure 1A). Almost all of these circulating NKT cells express CD161, while only a subset expresses CD56 (Figure 1A). We examined V24+V11+ NKT cells for expression of a panel of chemokine receptors. CCR1, a receptor expressed by few T cells, is expressed by about 60% of NKT cells (Figure 1B,C). Most NKT cells also express CCR2, CCR5, CCR6, CXCR3, and CXCR6. These chemokine receptors are expressed by T cells with homing potential to nonlymphoid tissues and are highly associated with inflammation.25 Almost all express CXCR4, a receptor also widely expressed by T, B, and monocytes. Few NKT cells express CCR3, CCR9, and CXCR5, which are mainly expressed by eosinophils (CCR3),21 thymocytes and gut homing lymphocytes (CCR9),22 or B cells and a subset of follicle homing CD4 T cells (CXCR5).23,26 CCR7, a chemokine receptor important for T-cell homing into lymphoid tissues,27-29 is expressed by only 10% to 28% (n = 6) of NKT cells. CCR4, a receptor implicated in lymphocyte homing to skin30 and expressed on most IL-4-producing CD4 T cells,31 is expressed by about 11% of NKT cells. Although the chemokine receptor expression pattern of NKT cells is somewhat similar to that of CD45RACD27+ CD8 T cells, a larger percentage of NKT cells express CCR1, CCR2, CCR6, and CXCR6 compared with this CD8 T-cell subset (Figure 1B,C). Despite the distinct expression pattern of chemokine receptors by NKT cells, it is notable that there are considerable variations among donors in the fraction of NKT cells expressing each chemokine receptor (Figure 1B). Chemokine receptor expression by NKT cell subsets Based upon expression of CD4 and/or CD8, 3 subsets of NKT cells, CD4+CD8 (CD4), CD4CD8+ (CD8), and CD4CD8 (DN), can be identified. The relative frequency of each subset differs considerably from person to person (Figure 2C). On average, 49% of V24+V11+ cells are DN, 27% are CD4, and 24% are CD8 NKT cells (n = 12). The wide variation in frequency of NKT cells expressing each chemokine receptor (Figure 1B) may be related to this variation of NKT cell subset composition and prompted us to individually examine chemokine receptor expression by each NKT cell subset. CCR1 is expressed by few cells of the CD4 subset but by most CD8 and DN cells (Figure 2A,B). Slightly, but consistently, more DN (than CD8) cells express CCR1. In a similar manner, CCR6 and CXCR6 are also preferentially expressed by DN and CD8 subsets. CCR2, CCR5, and CXCR3 are expressed by most of each NKT subset with slight differences (DN  CD8  CD4). In contrast, CCR4 is mainly expressed by the CD4 subset but by few cells in the CD8 or DN subset. There is no notable difference in expression of CCR7 among the NKT cell subsets. Thus, some receptors, CCR4 (CD4) and CCR1, CCR6 and CXCR6 (DN and CD8), are characteristically and differentially expressed by NKT cell subsets. It has been reported that human CD4+ NKT cells contain many more Th0-like cells producing IL-4 and IFN- than CD4 NKT cells.11 Here we examined the differences in cytokine production capacity among the CD4, CD8, and DN NKT subsets that display different chemokine receptor expression patterns. As previously reported, CD4 NKT cells were far better than other subsets in producing IL-4. CD8 NKT cells are slightly but consistently better than DN cells in producing IL-4 (Figure 2D). Notably, the 3 NKT cell subsets are very different also in production of IL-2. No significant difference was observed among the NKT cell subsets in producing IFN- and TNF-. Thus, the CD4 NKT cell subset contains most of the IL-2- and IL-4-producing NKT cells in circulation, while CD8 and DN NKT cells contain relatively few such cells. Chemokine responses of NKT cell subsets We examined the chemotactic response of NKT cell subsets to chemokines. MIP-1 (a CCR1 ligand) induced good chemotaxis of CD8 and DN NKT cells but poor chemotaxis of CD4 cells (Figure 3A). LARC (a CCR6 ligand) induced robust chemotaxis of CD8 and DN NKT cells but low chemotaxis of CD4 cells. In contrast, TARC (a CCR4 ligand) induced significant CD4 NKT cell migration but did not attract DN and CD8 NKT cells well. ELC (a CCR7 ligand) induced migration of all 3 subsets at similar levels. SDF-1 (the CXCR4 ligand), MCP-1 (a CCR2 ligand), and IP-10 (a CXCR3 ligand) attracted all 3 NKT cell subsets very well (Figure 3A), while BLC (the CXCR5 ligand), thymus-expressed chemokine (TECK) (the CCR9 ligand), and I-309 (a CCR8 ligand) did not show any notable chemotactic activity for NKT cells (not shown). View larger version (15K): [in this window] [in a new window]   Figure 3. Differential chemokine responses among NKT cell subsets. (A) Chemotactic responses of CD4, CD8, and DN NKT cell subsets. Cell migration is shown as net migration after subtraction of background migration. (B) Frequency of IL-2-, IL-4-, and IFN--producing NKT cells in chemotaxed cells after migration to TARC or LARC. Chemokines were used at the indicated concentration (A) or 250 ng/mL (TARC) and 1500 ng/mL (LARC) for panel B. Chemotaxed NKT cells were phenotyped by surface and/or intracellular cytokine staining followed by counting. Relative frequencies of cytokine producers were calculated by dividing numbers of cytokine-producing NKT cells after chemotaxis by those NKT cells in input (input = 1, marked by horizontal lines [B]). *Significant differences (P < .05) between CD4 and CD8 or DN NKT subsets (n = 4, [A]) or the 2 groups (n = 6 [B]). To further examine whether chemokines can differentially enrich cytokine producers versus nonproducers after chemotaxis, the frequencies of IL-2-, IL-4-, and IFN--producing NKT cells were compared to the input population after chemotaxis to TARC and LARC (Figure 3B). IL-2 and IL-4 producers were enriched in TARC-attracted, but not LARC-attracted, NKT cells. However, no considerable enrichment or depletion was observed for IFN- producers after chemotaxis to these chemokines. Thus, NKT cell subsets with distinct cytokine-producing capacities display differential responses to chemokines, and their chemokine response correlates well with the chemokine receptor expression pattern. Expression of other homing receptors by NKT cell subsets Along with chemokine receptors, adhesion molecules such as CD62L, CLA, and 47 are important for tissue-specific homing of leukocytes. CD62L is implicated in homing to peripheral lymph nodes, and it has been reported that human NKT cells are CD62Llow/.9,10 To migrate into T-cell areas of lymph nodes, cells are thought to also coexpress CCR7.27-29 Thus, we examined the existence of CD62L+CCR7+ NKT cells in circulation (Table 1). A small but distinct CD62L+CCR7+ subset is found within the NKT cell population. Most of these CD62L+CCR7+ NKT cells are CD4+, a few are DN, and virtually none are CD8+. Many NKT cells (60%-90%, n = 4) express a gut homing receptor, 47 (Table 1); this frequency is higher than that among conventional CD4 memory T cells (20%-30% are 47+). Expression of CLA, a skin homing receptor, is also detected on a subset (on average 7%-13%, n = 4) of NKT cells. Whereas CLA and 47 are largely mutually exclusive among conventional CD4 cells, many CLA+ NKT cells coexpress 47 (not shown).                                View this table: [in this window] [in a new window]   Table 1. Frequencies (%) of L selectin+ CCR7+, CLA+, and 47+ cells in each NKT cell subset in circulation     Discussion Top Abstract Introduction Materials and methods Results Discussion References Here we examined expression of chemokine receptors and homing receptors by a unique T-cell subset, V24+V11+ "NKT" cells. The definition of NKT cells is controversial, especially in mice, because not all CD1d-restricted cells express NK1.1 and some NK1.1+ T cells are not CD1d-restricted. Surrogate markers such as CD56 and CD161 do not specifically identify human NKT cells either, because few NKT cells express CD56, and non-NKT T cells can express CD56 and CD161 (Figure 1A). In human beings, identification with antibodies to TCR V24 and V114,11 or binding with -galactosylceramide-loaded CD1d tetramers32,33 appears to be the most specific way to identify NKT cells. Our results reveal existence not only of unique chemokine receptor expression patterns by NKT cells but also differential expression of trafficking machinery among NKT cell subsets. Our finding of differential chemokine receptor expression patterns correlates with the wide distribution of NKT cells in tissues. Most NKT cells express CCR1, CCR2, CCR5, CXCR3, CXCR4, and CXCR6. Among these, CCR1, CCR2, CCR5, CXCR3, and CXCR6 are highly associated with "tissue" T cells found in extralymphoid tissues.24,25,34 Their chemokine ligands (eg, MIP-1, MCP-1, MIP-1, IP-10) are widely expressed in extralymphoid tissues and up-regulated by inflammatory signals. Furthermore, most NKT cells also express 47, a homing receptor to gut-associated lymphoid systems. In contrast, CCR7, a receptor required for homing into lymphoid tissues and expressed by all naive T cells and many (about 70%) memory T cells, is expressed by only about 20% of NKT cells; the follicular homing receptor, CXCR5, is expressed by few NKT cells. Thus, the chemokine receptor expression pattern suggests that, unlike naive and memory T cells, most NKT cells have the machinery to localize in extralymphoid tissues, and only a small subset of NKT cells have a homing potential to secondary lymphoid tissues. NKT cells lack the expression of CXCR5, the chemokine receptor needed to localize in the B-cell area of lymphoid tissues,35 and thus are likely to be excluded from the B-cell areas including germinal centers. Whether blood NKT cells recirculate through peripheral lymph nodes remains unknown. In this regard, it is not clear whether the small number of NKT cells found in lymph nodes are generated in lymph nodes or migrate into the nodes via the afferent lymphs or the blood. Our results show that a small population of NKT cells in circulation expresses both CCR7 and L selectin and resides mainly within the CD4 NKT subset. L selectin and CCR7 mediate adhesive interactions of leukocytes and high endothelial venules for transmigration into lymphoid tissues, and CCR7 is required for T cells to localize in T-cell areas of lymphoid tissues in response to CCR7 ligands SLC and ELC. These chemokines are expressed by high endothelial venules (SLC, ELC) and mature DCs in T-cell areas (ELC). Therefore, the small population of NKT cells expressing CCR7 and L selectin can potentially migrate into sites of T-cell differentiation in secondary lymphoid organs. Interestingly, NKT cell subsets differ substantially in their expression of some chemokine receptors even though NKT cell subsets share expression of many chemokine receptors as discussed above. Most notably, CD4 NKT cells (high IL-2 and IL-4 producers) express CCR4 and are highly responsive to TARC, while CD8 and DN NKT cell subsets (low IL-2 and IL-4 producers) express CCR1, CCR6, and CXCR6 and respond very well to their ligands such as MIP-1 and LARC. Thus, our results show polarization in chemokine receptor expression and chemokine response among NKT cell subsets with distinct effector functions. It has been reported that chemokine receptors are associated with the effector cytokine production capacity of CD4 or CD8 T cells.36-38 CCR4 is expressed by almost all IL4-producing CD4 cells, while CXCR3 is expressed by almost all IFN--producing cells.31 T cells expressing CCR2, CCR5, and CXCR6 also contain many more IFN- producers than total memory T cells.31 Our results suggest that NKT cells also show such differential expression pattern of chemokine receptors. In the case of NKT cells, however, the association is somewhat skewed by the unusually uniform expression of tissue homing chemokine receptors: Most NKT cells express the Th1-associated chemokine receptors (CCR2, CCR5, and CXCR3) in a less discriminatory way, while they express CCR1, CCR4, CCR6, and CXCR6 more differentially. Tissue expression of chemokines provides insights into how NKT cells establish tissue tropisms. For example, the chemokine ligand of CCR6, a receptor expressed by the most NKT cells, is LARC, a chemokine mainly expressed in liver among various tissues.39 This is in good correlation with the enrichment of NKT cells in liver. Cytokines and inflammatory signals profoundly change the expression pattern of cytokines. Expression of LARC and -defensin (a nonchemokine CCR6 ligand) in epithelial cells or keratinocytes is greatly enhanced by bacterial endotoxin, IL-1, and TNF-.40,41 CCR4 ligands, TARC and MDC, are constitutively detected in thymus at high levels and in small intestine and lung at lower levels.34,42 Importantly, expression of TARC and MDC is induced by Th2 cytokines IL-4 and/or IL-13 in various cell types43,44 and in inflamed skin venules,30 amplifying the recruitment of CCR4+ T cells to sites of Th2 inflammation. The CXCR6 ligand, CXCL16, is expressed in liver and lung at high levels and in spleen and lymph nodes at low levels.45 Thus, depending on the expression of 2 types of chemokines (TARC vs LARC, MIP-1, and CXCL16) under normal and inflammatory conditions, recruitment of each NKT cell subset may be specifically controlled. Some differences in tissue localization have been observed at least in mice: There are more DN and CD8 than CD4 NKT cells in lungs, while the CD4 subset is the major NKT cell population in thymus.13 Although chemokine receptor expression and NKT cell localization in tissues could differ in human beings and mouse, our results suggest a potential mechanism to fine-control migration (or retention) of different NKT cell subsets. In conclusion, our results show that NKT cells almost universally express inflammatory lymphocyte chemokine receptors to levels that are much higher than any other memory or effector T-cell subsets examined and yet display distinct and subset-specific expression profiles of other chemokine receptors, including CCR4 (by CD4), CXCR6, CCR1, and CCR6 (by CD8 and DN). Furthermore, expression of human immunodeficiency virus coreceptors (CCR2, CCR5, CXCR4, and CXCR6) by many CD4 NKT cells suggests that they are potential targets of human immunodeficiency virus infection. The precise NKT cell subset-specific localization in various human tissues in normal and inflammatory conditions remains unknown. Therefore, this report on expression of chemokine and homing receptors would be valuable in helping explain and predict the localization of the circulating human NKT cell subsets.     Acknowledgments We thank Dr Lijun Wu (Millennium Pharmaceuticals) for reagents (anti-CCR4 and CCR7).     Footnotes Submitted December 7, 2001; accepted February 28, 2002. Prepublished online as Blood First Edition Paper April 17, 2002; DOI 10.1182/blood-2001- 12-0196. Supported by a special fellowship from the Leukemia and Lymphoma Society (C.H.K.); grants AI47822, GM37734, and AI37832 from the National Institutes of Health; an award from the Department of Veterans Affairs (E.C.B.); and the FACS Core facility of the Stanford Digestive Disease Center. The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734. Reprints: Chang H. Kim, 3801 Miranda Ave, Mail code 154-B, VAMC Building 101, Room C4-111, Palo Alto, CA 94304; e-mail: chkim{at}stanford.edu.     References Top Abstract Introduction Materials and methods Results Discussion References 1. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today. 2000;21:573-583[CrossRef][Medline] [Order article via Infotrieve]. 2. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol. 1997;15:535-562[CrossRef][Medline] [Order article via Infotrieve] 3. Porcelli S, Yockey CE, Brenner MB, Balk SP. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- / T cells demonstrates preferential use of several V  genes and an invariant TCR  chain. J Exp Med. 1993;178:1-16[Abstract/Free Full Text]. 4. Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A. An invariant V  24-J  Q/V  11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J Exp Med. 1994;180:1171-1176[Abstract/Free Full Text]. 5. Joyce S, Woods AS, Yewdell JW, et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science. 1998;279:1541-1544[Abstract/Free Full Text]. 6. Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of v14 NKT cells by glycosylceramides. Science. 1997;278:1626-1629[Abstract/Free Full Text]. 7. Schofield L, McConville MJ, Hansen D, et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science. 1999;283:225-229[Abstract/Free Full Text]. 8. Exley M, Porcelli S, Furman M, Garcia J, Balk S. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V  24 J  Q T cell receptor  chains. J Exp Med. 1998;188:867-876[Abstract/Free Full Text]. 9. van Der Vliet HJ, Nishi N, de Gruijl TD, et al. Human natural killer T cells acquire a memory-activated phenotype before birth. Blood. 2000;95:2440-2442[Abstract/Free Full Text]. 10. D'Andrea A, Goux D, De Lalla C, et al. Neonatal invariant V24+ NKT lymphocytes are activated memory cells. Eur J Immunol. 2000;30:1544-1550[CrossRef][Medline] [Order article via Infotrieve]. 11. Prussin C, Foster B. TCR V  24 and V  11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J Immunol. 1997;159:5862-5870[Abstract]. 12. Yoshimoto T, Paul WE. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med. 1994;179:1285-1295[Abstract/Free Full Text]. 13. Hammond KJ, Pelikan SB, Crowe NY, et al. NKT cells are phenotypically and functionally diverse. Eur J Immunol. 1999;29:3768-3781[CrossRef][Medline] [Order article via Infotrieve]. 14. Kadowaki N, Antonenko S, Ho S, et al. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med. 2001;193:1221-1226[Abstract/Free Full Text]. 15. Taniguchi M, Nakayama T. Recognition and function of V14 NKT cells. Semin Immunol. 2000;12:543-550[CrossRef][Medline] [Order article via Infotrieve]. 16. Eberl G, Lees R, Smiley ST, Taniguchi M, Grusby MJ, MacDonald HR. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol. 1999;162:6410-6419[Abstract/Free Full Text]. 17. Butcher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol. 1999;72:209-253[Medline] [Order article via Infotrieve]. 18. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science. 1999;286:2098-2102[Abstract/Free Full Text]. 19. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565-568[CrossRef][Medline] [Order article via Infotrieve]. 20. Kim CH, Broxmeyer HE. Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol. 1999;65:6-15[Abstract]. 21. Heath H, Qin S, Rao P, et al. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest. 1997;99:178-184[Medline] [Order article via Infotrieve]. 22. Zabel BA, Agace WW, Campbell JJ, et al. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med. 1999;190:1241-1256[Abstract/Free Full Text]. 23. Kim CH, Rott LS, Clark-Lewis I, Campbell DJ, Wu L, Butcher EC. Sub-specialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J Exp Med. 2001;193:1-10[Abstract/Free Full Text]. 24. Kim CH, Kunkel EJ, Boisvert J, et al. Bonzo/CXCR6 defines polarized Type 1 T cell subsets with extra-lymphoid tissue homing potential. J Clin Invest. 2001;107:595-601[Medline] [Order article via Infotrieve]. 25. Luster AD. Chemokineschemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436-445[Free Full Text]. 26. Forster R, Emrich T, Kremmer E, Lipp M. Expression of the G-protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. Blood. 1994;84:830-840[Abstract/Free Full Text]. 27. Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999;99:23-33[Medline] [Order article via Infotrieve]. 28. Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med. 2000;191:77-88[Abstract/Free Full Text]. 29. Stein JV, Rot A, Luo Y, et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med. 2000;191:61-76[Abstract/Free Full Text]. 30. Campbell JJ, Haraldsen G, Pan J, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 1999;400:776-780[CrossRef][Medline] [Order article via Infotrieve]. 31. Kim CH, Rott L, Kunkel EJ, et al. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest. 2001;108:1331-1339[CrossRef][Medline] [Order article via Infotrieve]. 32. Matsuda JL, Naidenko OV, Gapin L, et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med. 2000;192:741-754[Abstract/Free Full Text]. 33. Kronenberg M, Naidenko O, Koning F. Right on target: novel approaches for the direct visualization of CD1-specific T cell responses. Proc Natl Acad Sci U S A. 2001;98:2950-2952[Free Full Text]. 34. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, Yoshie O. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem. 1996;271:21514-21521[Abstract/Free Full Text]. 35. Cyster JG, Ansel KM, Reif K, et al. Follicular stromal cells and lymphocyte homing to follicles. Immunol Rev. 2000;176:181-193[CrossRef][Medline] [Order article via Infotrieve]. 36. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998;187:129-134[Abstract/Free Full Text]. 37. Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol. 1999;11:81-88[Abstract/Free Full Text]. 38. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998;187:875-883[Abstract/Free Full Text]. 39. Hieshima K, Imai T, Opdenakker G, et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem. 1997;272:5846-5853[Abstract/Free Full Text]. 40. Tanaka Y, Imai T, Baba M, et al. Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur J Immunol. 1999;29:633-642[CrossRef][Medline] [Order article via Infotrieve]. 41. Yang D, Chertov O, Oppenheim JJ. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol. 2001;69:691-697[Abstract/Free Full Text]. 42. Godiska R, Chantry D, Raport CJ, et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med. 1997;185:1595-1604[Abstract/Free Full Text]. 43. Kumagai N, Fukuda K, Nishida T. Synergistic effect of TNF- and IL-4 on the expression of thymus- and activation-regulated chemokine in human corneal fibroblasts. Biochem Biophys Res Commun. 2000;279:1-5[CrossRef][Medline] [Order article via Infotrieve]. 44. Andrew DP, Chang MS, McNinch J, et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J Immunol. 1998;161:5027-5038[Abstract/Free Full Text]. 45. Wilbanks A, Zondlo SC, Murphy K, et al. Expression cloning of the strl33/bonzo/tymstr ligand reveals elements of cc, cxc, and cx3c chemokines. J Immunol. 2001;166:5145-5154[Abstract/Free Full Text]. © 2002 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: R. Cullen, E. Germanov, T. Shimaoka, and B. Johnston Enhanced Tumor Metastasis in Response to Blockade of the Chemokine Receptor CXCR6 Is Overcome by NKT Cell Activation J. Immunol., November 1, 2009; 183(9): 5807 - 5815. [Abstract] [Full Text] [PDF] S. Hegde, E. Jankowska-Gan, D. A. Roenneburg, J. Torrealba, W. J. Burlingham, and J. E. Gumperz Human NKT cells promote monocyte differentiation into suppressive myeloid antigen-presenting cells J. Leukoc. Biol., October 1, 2009; 86(4): 757 - 768. [Abstract] [Full Text] [PDF] G. Bricard, V. Cesson, E. Devevre, H. Bouzourene, C. Barbey, N. Rufer, J. S. Im, P. M. Alves, O. Martinet, N. Halkic, et al. Enrichment of Human CD4+ V{alpha}24/V{beta}11 Invariant NKT Cells in Intrahepatic Malignant Tumors J. Immunol., April 15, 2009; 182(8): 5140 - 5151. [Abstract] [Full Text] [PDF] E. Germanov, L. Veinotte, R. Cullen, E. Chamberlain, E. C. Butcher, and B. Johnston Critical Role for the Chemokine Receptor CXCR6 in Homeostasis and Activation of CD1d-Restricted NKT Cells J. Immunol., July 1, 2008; 181(1): 81 - 91. [Abstract] [Full Text] [PDF] E. A. Jacobsen, S. I. Ochkur, R. S. Pero, A. G. Taranova, C. A. Protheroe, D. C. Colbert, N. A. Lee, and J. J. Lee Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells J. Exp. Med., March 17, 2008; 205(3): 699 - 710. [Abstract] [Full Text] [PDF] M. L. Allende, D. Zhou, D. N. Kalkofen, S. Benhamed, G. Tuymetova, C. Borowski, A. Bendelac, and R. L. Proia S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues FASEB J, January 1, 2008; 22(1): 307 - 315. [Abstract] [Full Text] [PDF] E. Galkina, B. L. Harry, A. Ludwig, E. A. Liehn, J. M. Sanders, A. Bruce, C. Weber, and K. Ley CXCR6 Promotes Atherosclerosis by Supporting T-Cell Homing, Interferon-{gamma} Production, and Macrophage Accumulation in the Aortic Wall Circulation, October 16, 2007; 116(16): 1801 - 1811. [Abstract] [Full Text] [PDF] S. Hegde, X. Chen, J. M. Keaton, F. Reddington, G. S. Besra, and J. E. Gumperz NKT cells direct monocytes into a DC differentiation pathway J. Leukoc. Biol., May 1, 2007; 81(5): 1224 - 1235. [Abstract] [Full Text] [PDF] M. Monteiro, C. Evaristo, A. Legrand, A. Nicoletti, and B. Rocha Cartography of gene expression in CD8 single cells: novel CCR7- subsets suggest differentiation independent of CD45RA expression Blood, April 1, 2007; 109(7): 2863 - 2870. [Abstract] [Full Text] [PDF] H. J. J. van der Vliet, M. G. A. van Vonderen, J. W. Molling, H. J. Bontkes, M. Reijm, P. Reiss, M. A. van Agtmael, S. A. Danner, A. J. M. van den Eertwegh, B. M. E. von Blomberg, et al. Cutting Edge: Rapid Recovery of NKT Cells upon Institution of Highly Active Antiretroviral Therapy for HIV-1 Infection J. Immunol., November 1, 2006; 177(9): 5775 - 5778. [Abstract] [Full Text] [PDF] J. S. Im, N. Tapinos, G.-T. Chae, P. A. Illarionov, G. S. Besra, G. H. DeVries, R. L. Modlin, P. A. Sieling, A. Rambukkana, and S. A. Porcelli Expression of CD1d Molecules by Human Schwann Cells and Potential Interactions with Immunoregulatory Invariant NK T Cells J. Immunol., October 15, 2006; 177(8): 5226 - 5235. [Abstract] [Full Text] [PDF] M. Horikawa, M. Fujimoto, M. Hasegawa, T. Matsushita, Y. Hamaguchi, A. Kawasuji, Y. Matsushita, T. Fujita, F. Ogawa, K. Takehara, et al. E- and P-Selectins Synergistically Inhibit Bleomycin-Induced Pulmonary Fibrosis Am. J. Pathol., September 1, 2006; 169(3): 740 - 749. [Abstract] [Full Text] [PDF] H. W. Lim, H. E. Broxmeyer, and C. H. Kim Regulation of Trafficking Receptor Expression in Human Forkhead Box P3+ Regulatory T Cells J. Immunol., July 15, 2006; 177(2): 840 - 851. [Abstract] [Full Text] [PDF] H. Lin, M. Nieda, J. F. Hutton, V. Rozenkov, and A. J. Nicol Comparative gene expression analysis of NKT cell subpopulations J. Leukoc. Biol., July 1, 2006; 80(1): 164 - 173. [Abstract] [Full Text] [PDF] Y. Huang, X.-Y. Zhu, M.-R. Du, X. Wu, M.-Y. Wang, and D.-J. Li Chemokine CXCL16, a scavenger receptor, induces proliferation and invasion of first-trimester human trophoblast cells in an autocrine manner Hum. Reprod., April 1, 2006; 21(4): 1083 - 1091. [Abstract] [Full Text] [PDF] O. Akbari, J. L. Faul, E. G. Hoyte, G. J. Berry, J. Wahlstrom, M. Kronenberg, R. H. DeKruyff, and D. T. Umetsu CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med., March 16, 2006; 354(11): 1117 - 1129. [Abstract] [Full Text] [PDF] N. J. Bahlis, M. Starovic, K. Raedschelders, K. Gratton, O. Bathe, and A. Belch PKC {delta} Inhibition Restores PTEN Activity in Myeloma Cells and Prolongs Survival of GFP+ Myeloma SCID/NOD Mice In Vivo. Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 113 - 113. [Abstract] Y. Jiang, H. Shang, Z. Zhang, Y. Diao, D. Dai, W. Geng, M. Zhang, X. Han, Y. Wang, and J. Liu Alterations of Natural Killer Cell and T-Lymphocyte Counts in Adults Infected with Human Immunodeficiency Virus through Blood and Plasma Sold in the Past in China and in Whom Infection Has Progressed Slowly over a Long Period Clin. Vaccine Immunol., November 1, 2005; 12(11): 1275 - 1279. [Abstract] [Full Text] [PDF] Y. Sen, B. Yongyi, H. Yuling, X. Luokun, H. Li, X. Jie, D. Tao, Z. Gang, L. Junyan, H. Chunsong, et al. V{alpha}24-Invariant NKT Cells from Patients with Allergic Asthma Express CCR9 at High Frequency and Induce Th2 Bias of CD3+ T Cells upon CD226 Engagement J. Immunol., October 15, 2005; 175(8): 4914 - 4926. [Abstract] [Full Text] [PDF] B. Chandrasekar, S. Mummidi, A. J. Valente, D. N. Patel, S. R. Bailey, G. L. Freeman, M. Hatano, T. Tokuhisa, and L. E. Jensen The Pro-atherogenic Cytokine Interleukin-18 Induces CXCL16 Expression in Rat Aortic Smooth Muscle Cells via MyD88, Interleukin-1 Receptor-associated Kinase, Tumor Necrosis Factor Receptor-associated Factor 6, c-Src, Phosphatidylinositol 3-Kinase, Akt, c-Jun N-terminal Kinase, and Activator Protein-1 Signaling J. Biol. Chem., July 15, 2005; 280(28): 26263 - 26277. [Abstract] [Full Text] [PDF] V. Sordi, M. L. Malosio, F. Marchesi, A. Mercalli, R. Melzi, T. Giordano, N. Belmonte, G. Ferrari, B. E. Leone, F. Bertuzzi, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets Blood, July 15, 2005; 106(2): 419 - 427. [Abstract] [Full Text] [PDF] H. W. van Deventer, W. O'Connor Jr., W. J. Brickey, R. M. Aris, J. P.Y. Ting, and J. S. Serody C-C Chemokine Receptor 5 on Stromal Cells Promotes Pulmonary Metastasis Cancer Res., April 15, 2005; 65(8): 3374 - 3379. [Abstract] [Full Text] [PDF] M. S. Duthie, M. Kahn, M. White, R. P. Kapur, and S. J. Kahn Critical Proinflammatory and Anti-Inflammatory Functions of Different Subsets of CD1d-Restricted Natural Killer T Cells during Trypanosoma cruzi Infection Infect. Immun., January 1, 2005; 73(1): 181 - 192. [Abstract] [Full Text] [PDF] D. V. Baev, X.-h. Peng, L. Song, J. R. Barnhart, G. M. Crooks, K. I. Weinberg, and L. S. Metelitsa Distinct homeostatic requirements of CD4+ and CD4- subsets of V{alpha}24-invariant natural killer T cells in humans Blood, December 15, 2004; 104(13): 4150 - 4156. [Abstract] [Full Text] [PDF] A. M. Tager, R. L. Kradin, P. LaCamera, S. D. Bercury, G. S. V. Campanella, C. P. Leary, V. Polosukhin, L.-H. Zhao, H. Sakamoto, T. S. Blackwell, et al. Inhibition of Pulmonary Fibrosis by the Chemokine IP-10/CXCL10 Am. J. Respir. Cell Mol. Biol., October 1, 2004; 31(4): 395 - 404. [Abstract] [Full Text] [PDF] J. K. Sandberg, C. A. Stoddart, F. Brilot, K. A. Jordan, and D. F. Nixon Development of innate CD4+ {alpha}-chain variable gene segment 24 (V{alpha}24) natural killer T cells in the early human fetal thymus is regulated by IL-7 PNAS, May 4, 2004; 101(18): 7058 - 7063. [Abstract] [Full Text] [PDF] L. S. Metelitsa, H.-W. Wu, H. Wang, Y. Yang, Z. Warsi, S. Asgharzadeh, S. Groshen, S. B. Wilson, and R. C. Seeger Natural Killer T Cells Infiltrate Neuroblastomas Expressing the Chemokine CCL2 J. Exp. Med., May 3, 2004; 199(9): 1213 - 1221. [Abstract] [Full Text] [PDF] B. Chandrasekar, S. Bysani, and S. Mummidi CXCL16 Signals via Gi, Phosphatidylinositol 3-Kinase, Akt, I{kappa}B Kinase, and Nuclear Factor-{kappa}B and Induces Cell-Cell Adhesion and Aortic Smooth Muscle Cell Proliferation J. Biol. Chem., January 30, 2004; 279(5): 3188 - 3196. [Abstract] [Full Text] [PDF] Y. Yang, A. Ueno, M. Bao, Z. Wang, J. S. Im, S. Porcelli, and J.-W. Yoon Control of NKT Cell Differentiation by Tissue-Specific Microenvironments J. Immunol., December 1, 2003; 171(11): 5913 - 5920. [Abstract] [Full Text] [PDF] B. Johnston, C. H. Kim, D. Soler, M. Emoto, and E. C. Butcher Differential Chemokine Responses and Homing Patterns of Murine TCR{alpha}{beta} NKT Cell Subsets J. Immunol., September 15, 2003; 171(6): 2960 - 2969. [Abstract] [Full Text] [PDF] S. Y. Thomas, R. Hou, J. E. Boyson, T. K. Means, C. Hess, D. P. Olson, J. L. Strominger, M. B. Brenner, J. E. Gumperz, S. B. Wilson, et al. CD1d-Restricted NKT Cells Express a Chemokine Receptor Profile Indicative of Th1-Type Inflammatory Homing Cells J. Immunol., September 1, 2003; 171(5): 2571 - 2580. [Abstract] [Full Text] [PDF] F. Dieli, M. Taniguchi, M. Kronenberg, S. Sidobre, J. Ivanyi, L. Fattorini, E. Iona, G. Orefici, G. De Leo, D. Russo, et al. An Anti-Inflammatory Role for V{alpha}14 NK T cells in Mycobacterium bovis Bacillus Calmette-Guerin-Infected Mice J. Immunol., August 15, 2003; 171(4): 1961 - 1968. [Abstract] [Full Text] [PDF] A. Motsinger, A. Azimzadeh, A. K. Stanic, R. P. Johnson, L. Van Kaer, S. Joyce, and D. Unutmaz Identification and Simian Immunodeficiency Virus Infection of CD1d-Restricted Macaque Natural Killer T Cells J. Virol., July 15, 2003; 77(14): 8153 - 8158. [Abstract] [Full Text] [PDF] A. A. Maghazachi G protein-coupled receptors in natural killer cells J. Leukoc. Biol., July 1, 2003; 74(1): 16 - 24. [Abstract] [Full Text] [PDF] C. Tsutsumi, K.-H. Sonoda, K. Egashira, H. Qiao, T. Hisatomi, S. Nakao, M. Ishibashi, I. F. Charo, T. Sakamoto, T. Murata, et al. The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization J. Leukoc. Biol., July 1, 2003; 74(1): 25 - 32. [Abstract] [Full Text] [PDF] G. Galli, S. Nuti, S. Tavarini, L. Galli-Stampino, C. De Lalla, G. Casorati, P. Dellabona, and S. Abrignani CD1d-restricted Help To B Cells By Human Invariant Natural Killer T Lymphocytes J. Exp. Med., April 21, 2003; 197(8): 1051 - 1057. [Abstract] [Full Text] [PDF] E. Beutler, A. V. Hoffbrand, and J. D. Cook Iron Deficiency and Overload Hematology, January 1, 2003; 2003(1): 40 - 61. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) All Versions of this Article: 2001-12-0196v1 100/1/11    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kim, C. H. Articles by Butcher, E. C. Search for Related Content PubMed PubMed Citation Articles by Kim, C. H. Articles by Butcher, E. C. Related Collections Immunobiology Chemokines, Cytokines, and Interleukins Social Bookmarking                   What's this?

	Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020